Time-dependent apoptotic responses to vitamin E in precancerous lesions-on- chip models

АУТОР(И) / AUTHOR(S): Ana Mirić, Anđela Perić, Jelena Košarić, Nevena Milivojević Dimitrijević, Petar Arsenijević, Marko Živanović, Nenad Filipović

Download Full Pdf   

DOI:  10.46793/ICCBIKG25.382M

САЖЕТАК / ABSTRACT:

Cervical cancer remains a major global health issue, especially in low- and middle- income countries, with around 660,000 cases and 350,000 deaths in 2022—94% in these regions. Persistent high-risk HPV infection, along with smoking, poor nutrition, inflammation, and immunosuppression, contributes to the progression from LSIL to HSIL and cancer. This study examined how antioxidant treatments—vitamin E and Ialuna®—affect apoptosis in cervical tissue cultured in microfluidic organ-on-a-chip devices, using Bax/Bcl-2 gene expression. Cervical biopsies and a control cell line were cultured in PDMS chips and treated with vitamin E or Ialuna®. Vitamin E triggered an early apoptotic response, especially in LSIL and early HSIL, while Ialuna® induced a slower, sustained effect, notably in HSIL and chronic cervicitis. Bax/Bcl-2 ratios peaked at 144 hours in chronic cervicitis with vitamin E and in HSIL with Ialuna®. This platform offers a promising tool for personalized therapy, supporting a dual antioxidant strategy based on lesion severity and treatment timing.

КЉУЧНЕ РЕЧИ / KEYWORDS:

Bax/Bcl-2 ratio, cervical cancer, HSIL, LSIL, microfluidic chip devices

ПРОЈЕКАТ / ACKNOWLEDGEMENT:

The research was funded by the Ministry of Science, Technological Development and Innovation of the Republic of Serbia, contract number [451-03-136/2025-03/200378 (Institute for Information Technologies Kragujevac, University of Kragujevac)].

ЛИТЕРАТУРА / REFERENCES:

• A. Alrajjal, V. Pansare, MSR. Choudhury, MYA. Khan, VB. Shidham, Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System, Cytojournal, 17 (2021), 16-18.
• A. Shrivastava et al, Serum vitamin A, E and C status in cervical cancer patients undergoing Concurrent Chemo-Radiotherapy, an institutional study, Journal of Nutrition and Intermediary Metabolism, 18 (2019) 100107.
• S. Ebrahimi, A. Soltani, S.I. Hashemy, Oxidative stress in cervical cancer pathogenesis and resistance to therapy J. Cell, Biochemstry, 120 (2019) 6868-6877.
• A. Alrajjal et al, Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System, Cytojournal, 17 (2021) 19-16.
• KD. Quint, MN. de Koning, WG. Quint, EC. Pirog, Progression of cervical low grade squamous intraepithelial lesions: in search of prognostic biomarkers, Eur J Obstet Gynecol Reprod Biology, 170 (2013) 501-506.
• D. Egemen et al, Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines, J Low Genit Tract Dis, 24 (2020) 132-133.
• S. Das et al, Prognostic significance of Bcl-2 expression in carcinoma of the uterine cervix: A systematic review and meta-analysis. Journal of Laboratory Physicians, (2025).
• S. Vishwas et al, Microfuidic chips: recent advances, critical strategies in design, applications and future perspectives, Microfuid Nanofuidics, (2021) 25-99.
• N. Milivojević et al, Evaluation of novel dendrimer-gold complex nanoparticles for theranostic application in oncology, Nanomedicine, 6 (2024) 483-497.
• M. Živanović et al, Combined Biological and Numerical Modeling Approach for Better Understanding of the Cancer Viability and Apoptosis, Pharmaceutics, 6 (2023) 1628.
• KJ. Livak, TD. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 4 (2001) 402-408.